biotactical B.V.

Direct Message
Website
Share
Export data
May 27, 2024
Data is self reported

biotactical B.V.

biotactical is developing a Rapid Microbial Method for pharmaceutical manufacturers and CDMO’s to help reduce the waiting time of 14-21 days to 48-72 hours, cut costs and deliver life saving therapies faster with our easy to use assay kit and ultra-sensitive instrument.

Achievement

Successful Proof of Concepts with 3 pharmaceutical products: 1: mRNA vaccine 2. General vaccine 3. CAR-T therapy Provided result within 48-72 hours and shown side-by-side comparison with our competitor.

Founded in

2023

Country

Netherlands

Industry

BioTech, MedTech, Health

SDGs

Good health and well-being (SDG #3), Clean water and sanitation (SDG #6)

Patent information

Our technology is patentable - working on the patent strategy. We will use part of the pre-seed round for the patent filing.

Team

Number of founders

pre-revenue

Number of employees

No

Founder backgrounds

McKinsey, Stripe

Exit experience

No

Relevant industry experience

Yes

Previous startup experience

Yes

Female founder

No

In the news

Investment details

Amount raising

500000

Ownership founders

80-99% owned by founders

Lead investor

imec.istart.nl

Current investors

Personal Founder A: 70000 ELF (loan): 60000 imec.istart.nl: 120000

Intended closing date

Q2 of this year

Fundraising status

Actively fundraising (brand name visible)

Already committed

50000

Revenue Metrics

Monthly revenue

pre-revenue

Monthly growth

not growing

Paying customers

0

Monthly active users

0

biotactical B.V.

saving...
biotactical is developing a Rapid Microbial Method for pharmaceutical manufacturers and CDMO’s to help reduce the waiting time of 14-21 days to 48-72 hours, cut costs and deliver life saving therapies faster with our easy to use assay kit and ultra-sensitive instrument.
Direct MessageSend Message

Premium Details Available

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
blurred values
Growth rate month over month
blurred values
Monthly revenue context
blurred values
Number of paying customers
blurred values
Monthly active users
blurred values

INVESTMENTS

Do you have a lead investor?
blurred values
How much have you raised in the past?
blurred values
How much of this round already committed?
blurred values
When are you aiming to close this round?
blurred values

TEAM

How much time do the founders spend on the business?
blurred values
Is there a founder with previous co-founder / c-level at startup experience?
blurred values
Is there a founder with previous Sector Experience?
blurred values
Is there a founder with previous Exit Experience?
blurred values
What percentage of company is owned by founders?
blurred values
Is there a women founder with at least 5% of the shares?
blurred values
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
blurred values
Graduation year from EUR, Erasmus MC or TUDelft
blurred values

OTHER

Year founded
blurred values
Patent status
blurred values
Start your free trial today to explore this information.
‍
Start Free Trial

Premium Details

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
pre-revenue
Growth rate month over month
not growing
Monthly revenue context
Number of paying customers
0
Monthly active users
0

INVESTMENTS

Do you have a lead investor?
imec.istart.nl
How much have you raised in the past?
Personal Founder A: 70000 ELF (loan): 60000 imec.istart.nl: 120000
How much of this round already committed?
50000
When are you aiming to close this round?
Q2 of this year

TEAM

How much time do the founders spend on the business?
Is there a founder with previous co-founder / c-level at startup experience?
Yes
Is there a founder with previous Sector Experience?
Yes
Is there a founder with previous Exit Experience?
No
What percentage of company is owned by founders?
80-99% owned by founders
Is there a women founder with at least 5% of the shares?
No
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
None of these
Graduation year from EUR, Erasmus MC or TUDelft

OTHER

Year founded
2023
Patent status
Our technology is patentable - working on the patent strategy. We will use part of the pre-seed round for the patent filing.

Basic details

Amount raising
500000
Country
Netherlands
Industry
BioTech, MedTech, Health
Website
https://www.biotactical.nl
Founders
linkedin profile of founderlinkedin profile of founderlinkedin profile of founder
Last updated:
May 27, 2024

Key Achievements

  • Successful Proof of Concepts with 3 pharmaceutical products: 1: mRNA vaccine 2. General vaccine 3. CAR-T therapy Provided result within 48-72 hours and shown side-by-side comparison with our competitor.

Contact this startup to discuss investments

Try it! It's free, no account needed.
This startup has indicated interest to meet with potential investors. If you are interested, please fill out the contact form below and your message will be forwarded to the startup.
Oops! Something went wrong while sending your message.

Provide anonymous feedback

Startups greatly benefit from honest feedback from investors, but rarely receive it for numerous reasons. You can anonymously provide feedback here.
Your name and email address is not shared with the startup, but needed to avoid misusage.
Oops! Something went wrong while sending your message.
Get Investor IntroductionsFind Startup InvestorsPartners & Deals
Startup Fountain
Privacy PolicyTerms & ConditionsAdd your StartupAdd InvestorInvite StartupsInvestor & Startup CategoriesSign upLoginContact me